Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 585 clinical trials
Featured trial
A Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

Parkinson's Disease (PD). The secondary objective of this study is to evaluate the pharmacokinetic (PK) profile of BIIB094.The study is open for PD patients with verified presence or absence of mutations in the

dyskinesia
  • 807 views
  • 18 May, 2022
  • 14 locations
Featured trial
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)

Parkinson's Disease (PD) who are on stable symptomatic PD medication.

resting tremor
SPECT Scan
bradykinesia
parkinsonism
early parkinson's
  • 99 views
  • 09 May, 2022
  • 109 locations
Featured trial
A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80

In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). In this study: Participants will take 225

  • 0 views
  • 18 May, 2022
Featured trial
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to placebo in subjects with early Parkinson's

early parkinson's
  • 0 views
  • 03 May, 2022
  • 70 locations
Featured trial
Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

The main purpose of this study is to examine the efficacy and safety of a repeated dosing ketamine infusion paradigm compared to placebo in individuals with PD.

hoehn and yahr scale
depression
depressed mood
depressive disorder
ketamine
  • 6 views
  • 12 May, 2022
  • 1 location
Featured trial
Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease

This study is a single-site, double-blinded, randomized clinical trial designed to elucidate mechanism(s) of action for symptomatic benefits observed in Parkinson's disease (PD)

dopamine
motor symptoms
  • 0 views
  • 18 May, 2022
  • 1 location
Featured trial
Study in Parkinson Disease of Exercise (SPARX3)

primary objective is to test whether the progression of the signs of Parkinson's disease is attenuated at 12 months in among persons who have not initiated medication for Parkinson Disease (PD) when they

datscan
SPECT Scan
movement disorder
  • 146 views
  • 25 Apr, 2022
  • 25 locations
Featured trial
Parkinson's Disease

IS YOUR CURRENT PARKINSON’S MEDICATION NOT ENOUGH? Learn about a Parkinson’s Research Study at Wake Research in Raleigh, NC.

  • 6 views
  • 15 Feb, 2022
  • 1 location
Featured trial
Genotypic Influences on Network Progression in Parkinson's Disease

GBA gene are the most common genetic risk factors for Parkinson's, affecting about 10 percent of the more than 6 million people estimated to have the disease.  Through prior research

antiparkinsonian agents
  • 39 views
  • 01 Feb, 2022
  • 1 location
Featured trial
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Parkinson's disease and cognitive impairment.  

cognitive impairment
movement disorder
dementia
  • 146 views
  • 24 Jan, 2020
  • 1 location